Patents Assigned to Korea Sangsa Co., Ltd.
  • Patent number: 8906391
    Abstract: Disclosed is a thermorod capable of actively releasing drugs according to temperature of the thermorod and a method of manufacturing the same. The thermorod generates heat by eddy current loss and hysteresis loss in an induced magnetic field. The thermorods can effectively administer drugs, such as anti-cancer drugs, since the thermorods may be used to perform local hyperthermia at 36.5° C. or above and to actively control the active drug release and delivery according to temperature as well. The thermorods may be useful in the treatment of resting tumor cells along with hyperthermia by performing a surgical operation on lesion sites of biological tissues. Using the thermorod, the drug is effectively delivered to an affected part in response to the active drug release. This can minimize the toxicity caused by an increase in blood drug concentration, which occurs when a drug is administered by a conventional method.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: December 9, 2014
    Assignees: Korea Sangsa Co., Ltd.
    Inventors: Young Kon Kim, Jae Geun Park, Sang Guon Lee, Woon Sub Baek
  • Publication number: 20110034871
    Abstract: Disclosed is a thermorod for active drug release capable of actively releasing drugs according to temperature and a method of manufacturing the same. The method for manufacturing a thermorod for active drug release that generates heat by means of eddy current loss and hysteresis loss in an induced magnetic field comprises: processing the thermorod into a certain shape; preparing a mixed-drug specimen by mixing a drug with a high molecular compound acting as a support of the drug; and forming a mixed-drug layer on the surface of the thermorod by using the mixed-drug specimen. Also, the thermorod for active drug release manufactured by the method is provided. Therefore, the method and thermorod prepared by the method may be useful to effectively perform the drug administration and anti-cancer drug treatment of affected parts since they may be used to perform local hyperthermia at 36.5° C. or above and to actively control the active drug release and delivery according to temperature as well.
    Type: Application
    Filed: October 20, 2010
    Publication date: February 10, 2011
    Applicant: KOREA SANGSA CO., LTD.
    Inventors: Young Kon Kim, Jae Geun Park, Sang Guon Lee, Woon Sub Baek
  • Patent number: 7604860
    Abstract: Provided are the high tensile nonmagnetic stainless steel wire for an low loss overhead electric conductor, the low loss overhead electric conductor using the high tensile nonmagnetic stainless steel wire as its core, and a manufacturing method of them respectively. The high tensile nonmagnetic stainless steel wire reduces a core loss and eddy current loss and minimizes effective electric resistance of the conductor by using the nonmagnetic stainless steel wire, that is a non-magnetic material, rather than a high carbon steel wire, that is a strong magnetic material. In addition, an overall power transmission loss is minimized by strengthening the tensile strength of and reducing a sectional area of the steel wire, making an aluminium-welded layer thicker, and increasing the sectional area of an aluminium conductor.
    Type: Grant
    Filed: May 25, 2004
    Date of Patent: October 20, 2009
    Assignees: Korea Sangsa Co., Ltd., Korea Electro Technology Research Institute
    Inventors: Byung Geol Kim, Shang Shu Kim, Byung Chul Woo, Hee Woong Lee, Ju Hwan Park, Yong Keun Jeong, Min Bum Lee, Sun Hwan Ahn